SGK1: a novel prognostic marker and potential drug target in medulloblastoma

被引：0
|
作者：
Pleier, S. [1 ,2 ]
Sturm, D. [1 ]
Remke, M. [1 ,2 ]
Witt, H. [1 ,2 ]
Goidts, V [1 ,2 ]
Reifenberger, G. [3 ]
Felsberg, J. [3 ]
Kulozik, A. E. [2 ]
Korshunov, A. [4 ]
Lichter, P. [1 ]
Pfister, S. M. [1 ,2 ]
机构：
[1] German Canc Res Ctr Heidelberg, Div Mol Genet, Heidelberg, Germany
[2] Univ Heidelberg Hosp, Dept Pediat Oncol Hematol & Immunol, Heidelberg, Germany
[3] Univ Dusseldorf, Dept Neuropathol, D-4000 Dusseldorf, Germany
[4] Univ Heidelberg Hosp, Dept Neuropathol, Heidelberg, Germany
来源：
KLINISCHE PADIATRIE | 2011年 / 223卷 / 03期
关键词：
D O I：
10.1055/s-0031-1277081
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
20
引用
收藏
页码：197 / 198
页数：2
相关论文
共 50 条
  • [41] SGK1, a potential regulator of c-fms related breast cancer aggressiveness
    Tangir, J
    Bonafé, N
    Gilmore-Hebert, M
    Henegariu, O
    Chambers, S
    CLINICAL & EXPERIMENTAL METASTASIS, 2004, 21 (06) : 477 - 483
  • [42] Review about the multi-target profile of resveratrol and its implication in the SGK1 inhibition
    Catalogna, Giada
    Moraca, Federica
    D'Antona, Lucia
    Dattilo, Vincenzo
    Perrotti, Giuseppe
    Lupia, Antonio
    Costa, Giosue
    Ortuso, Francesco
    Iuliano, Rodolfo
    Trapasso, Francesco
    Amato, Rosario
    Alcaro, Stefano
    Perrotti, Nicola
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 183
  • [43] LSD 1 is a Potential Therapeutic Target in Medulloblastoma
    Pajtler, K.
    Thor, T.
    Oles, L.
    Baumann, M.
    Heukamp, L. C.
    Buettner, R.
    Kirjel, J.
    Schramm, A.
    Eggert, A.
    Schulte, J.
    KLINISCHE PADIATRIE, 2009, 221 (03): : 203 - 204
  • [44] Discovery of novel 4-trifluoromethyl-2-anilinoquinoline derivatives as potential anti-cancer agents targeting SGK1
    Xu, Guangcan
    Li, Lanlan
    Lv, Mengfan
    Li, Cheng
    Yu, Jia
    Zeng, Xiaoping
    Meng, Xueling
    Yu, Gang
    Liu, Kun
    Cheng, Sha
    Luo, Heng
    Xu, Bixue
    MOLECULAR DIVERSITY, 2024,
  • [45] SMC4, a novel tumor prognostic marker and potential tumor therapeutic target
    Zhao, Zonglei
    Wang, Xixiu
    Ding, Yan
    Cao, Xuefeng
    Zhang, Xingyuan
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [46] Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer
    Yu Zhang
    Meng Zhang
    Fudong Yu
    Su Lu
    Huimin Sun
    Huamei Tang
    Zhihai Peng
    Journal of Experimental & Clinical Cancer Research, 34
  • [47] Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer
    Zhang, Yu
    Zhang, Meng
    Yu, Fudong
    Lu, Su
    Sun, Huimin
    Tang, Huamei
    Peng, Zhihai
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2015, 34
  • [48] Role of Ventral Tegmental Area SGK1 Phosphorylation and Activity in Drug-Associated Behaviors
    Doyle, Marie
    Bali, Vedrana
    Kaska, Sophia
    Cooper, Sarah
    Mazei-Robison, Michelle
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S623 - S624
  • [49] Pannexin: potential new target and prognostic marker for melanoma
    Lake, Francesca
    FUTURE ONCOLOGY, 2012, 8 (10) : 1221 - 1221
  • [50] Pannexin: potential new target and prognostic marker for melanoma
    Lake, Francesca
    EXPERT REVIEW OF PROTEOMICS, 2012, 9 (05) : 483 - 483
12345